Skip to main content

Blue Note Therapeutics

San Francisco, United States

Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.

$5.2M raised
Sep 2021
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Blue Note Therapeutics

How much funding has Blue Note Therapeutics raised?
Blue Note Therapeutics has raised $5.2M in total funding. The most recent round was Series A. The last funding was announced in September 2021.
Who are Blue Note Therapeutics's investors?
Blue Note Therapeutics's investors include Alumni Ventures, Memorial Sloan - Kettering Cancer Center, Jazz Venture Partners, Green D Ventures, Summer VC.
Where is Blue Note Therapeutics headquartered?
Blue Note Therapeutics is headquartered in San Francisco, United States.
What does Blue Note Therapeutics do?
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.
What stage is Blue Note Therapeutics at?
Blue Note Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Blue Note Therapeutics — Funding & Investors." VCBacked, September 9, 2021, https://www.vcbacked.co/company/blue-note-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2021). Blue Note Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/blue-note-therapeutics
Wikipedia (cite web)
{{cite web |title=Blue Note Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/blue-note-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .